📋 RAPT Therapeutics, Inc. (RAPT) - financial_results
Filing Date: 2022-05-11
Accepted: 2022-05-11 08:10:56
Event Type: financial_results
Event Details:
RAPT Therapeutics, Inc. (RAPT) Reports {period} Financial Results
RAPT Therapeutics, Inc. (RAPT) announced its financial results for the period ending 2022-05-11.
Key Financial Highlights:
Revenue: 241
Net Income: Not disclosed
EPS: Not disclosed
Cash and equivalents: 32418
No specific business highlights were provided.
targeting C-C motif chemokine receptor 4 (CCR4), for the treatment of inflammation and cancer, respectively. The Company is also pursuing a range of targets that are in the discovery stage of development. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995
📋 RAPT Therapeutics, Inc. (RAPT) - financial_results
Filing Date: 2022-05-11
Accepted: 2022-05-11 08:10:56
Event Type: financial_results
Event Details:
- Revenue: 241
- Net Income: Not disclosed
- EPS: Not disclosed
- Cash and equivalents: 32418
No specific business highlights were provided.📊 Key Financial Metrics (Year-over-Year Comparison):
Structured Data:
🔬 Clinical Trial Updates:
💼 Business Developments: